Therefore, the combination of antibiotics and inhibitors of immune checkpoints as well as inhibitors of protumor signaling (TUBB/Rho/ROCK) will provide novel possibilities for treating patients with PC. This evidence concerns the gene RHO and pachyonychia congenita.